Related Experiment Video

Updated: Jun 4, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer

Rong Hu1, Samuel R Denmeade, Jun Luo

  • 1Johns Hopkins University, 600 North Wolfe Street, 411 Marburg Building, Baltimore, MD 21287, USA.

Expert Review of Endocrinology & Metabolism
|February 15, 2011
PubMed

Insights

Understanding why prostate cancer patients respond differently to hormone therapy is crucial. Research into androgen receptor signaling and its variants may lead to better ways to predict and manage treatment resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Urology

Background:

  • Hormone therapies targeting androgen receptor (AR) signaling are standard for advanced prostate cancer.
  • Patient response to hormone therapy varies significantly, with outcomes for prolonged remission remaining unclear.
  • The AR signaling pathway is central to castration resistance and a primary target for prostate cancer drug development.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying variable patient responses to hormone therapy for advanced prostate cancer.
  • To explore the role of androgen receptor signaling pathway and its variants in the development of castration resistance.
  • To identify opportunities for developing novel clinical strategies for predicting, monitoring, or preventing prostate cancer progression.

Main Methods:

  • Analysis of molecular processes involved in castration-resistant prostate cancer (CRPC) development.
  • Characterization of androgen receptor (AR) signaling pathway.
  • Identification and study of AR splicing variants.

Main Results:

  • Variable patient responses to hormone therapy are linked to the androgen receptor signaling pathway.
  • Androgen receptor splicing variants are implicated in the development of castration resistance.
  • Understanding these molecular mechanisms offers potential for new therapeutic approaches.

Conclusions:

  • The androgen receptor signaling pathway is a key determinant of treatment response and resistance in advanced prostate cancer.
  • Further research into AR variants can inform the development of predictive biomarkers and novel therapeutic strategies.
  • Targeting AR signaling and its variants presents opportunities to improve patient outcomes in castration-resistant prostate cancer.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...